UK guidelines on 18F-fluciclovine PET/CT in prostate cancer imaging.
Journal
Nuclear medicine communications
ISSN: 1473-5628
Titre abrégé: Nucl Med Commun
Pays: England
ID NLM: 8201017
Informations de publication
Date de publication:
Jul 2019
Jul 2019
Historique:
pubmed:
31
5
2019
medline:
26
11
2019
entrez:
31
5
2019
Statut:
ppublish
Résumé
The purpose of these guidelines is to assist specialists in Nuclear Medicine and Radionuclide Radiology in recommending, performing, interpreting and reporting F-fluciclovine PET/computed tomography. It should be recognised that adherence to the guidance in this document will not assure an accurate diagnosis or a successful outcome. These guidelines will assist individual departments in the formulation of their own local protocols. The guidelines apply to studies on adults. All that should be expected is that the practitioner will follow a reasonable course of action based on current knowledge, available resources and the needs of the patient in order to deliver effective and safe medical care.
Identifiants
pubmed: 31145206
doi: 10.1097/MNM.0000000000001030
doi:
Substances chimiques
Carboxylic Acids
0
Cyclobutanes
0
fluciclovine F-18
38R1Q0L1ZE
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
662-674Subventions
Organisme : Medical Research Council
ID : MC_PC_16048
Pays : United Kingdom